FDA Abruptly Halts Progress on Next Seasons Flu Shots
The scheduled meeting to begin planning this fall's flu vaccine has been canceled by the Food and Drug Administration. Members of the Vaccines and Related Biological Products Advisory Committee (VRBPAC), who advise the FDA on expected flu strains to be targeted by the vaccine, said they were told the meeting was canceled, the New York Times reports. The U.S. Centers for Disease Control says VRBPAC "makes the final decision about which vaccine viruses to include in the composition of domestic flu vaccines," using research on which flu strains are "most likely to spread and cause illness.
Read More >> Full Article on Source: HBR MAG
#US #ShowBiz #Sports #Politics #Celebs
